About this trial
Lower EEG alpha band power is currently extensively studied as a potential biomarker of brain vulnerability. No previous study has evaluated whether there was a difference in EEG power spectrum ranges between propofol and sevoflurane, the two main anesthetic agents for maintenance of general anesthesia, in order to define a cut-off value for the prediction of a higher risk of postoperative delirium.
* Primary objective: comparison of EEG alpha power (dB) during maintenance of anesthesia with propofol and sevoflurane using data available in the NeuroSense® depth-of-anesthesia monitoring * Secondary objectives: comparison of other EEG frequency bands during maintenance of anesthesia with propofol and sevoflurane using data from the NeuroSense® depth-of-anesthesia monitoring
Eligibility criteria
Qualifiers
Capable to give informed consent
French-speaking patients
Disqualifiers
Need for a premedication with benzodiazepine before anesthesia
Reduced left ventricular ejection fraction (< 50%) or underlying cardiac pathology requiring a more balanced anesthesia (administration of benzodiazepine and/or ketamine during anesthesia)
Preoperative MoCA score < 26/30 (for patients > ou = 55 years old)
Patients treated with anti-epileptic drugs
Trial design
Treatments tested in this trial
- Maintenance of general anesthesia by Propofol
- Maintenance of general anesthesia by Sevoflurane